Towa Pharmaceutical (4553.T) Earnings Analysis
Towa Pharmaceutical (4553.T) next reports earnings on 2026-08-06. Last quarter (2026-05-14) it missed with EPS -240.35 JPY vs 107.89 JPY est (-322.8%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 38.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4553.T next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 71.38B |
4553.T earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -240.35 JPY | 107.89 JPY | -322.8% | Miss |
| 2026-02-13 | 180.15 JPY | 73.56 JPY | +144.9% | Beat |
| 2025-11-10 | 115.8 JPY | 62.02 JPY | +86.7% | Beat |
| 2025-08-07 | 51.06 JPY | 63.46 JPY | -19.5% | Miss |
| 2025-05-15 | 88.61 JPY | 113.89 JPY | -22.2% | Miss |
| 2025-02-13 | 163.93 JPY | 57.66 JPY | +184.3% | Beat |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
4553.T valuation and analyst view
| Trailing P/E | 38.58 |
|---|---|
| Trailing EPS | 106.65 JPY |
| Price / book | 1.14 |
| Dividend yield | 1.94% |
| Market cap | 207.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Towa Pharmaceutical (4553.T)'s next earnings date?
Towa Pharmaceutical is next scheduled to report on 2026-08-06 and revenue estimate of 71.38B.
Did 4553.T beat earnings last quarter?
In its 2026-05-14 report, 4553.T posted EPS of -240.35 JPY versus a 107.89 JPY estimate — a miss of 322.8%.
What is 4553.T's earnings track record?
Over the last 6 reported quarters with consensus data, 4553.T beat estimates 3 times (50%).
What is 4553.T's current P/E ratio and EPS?
4553.T trades at a trailing P/E of 38.58 on trailing EPS of 106.64662387259283 JPY.
What do analysts rate 4553.T?
4553.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.